{"disease":{"id":"immunosuppressive-agents","name":"immunosuppressive agents"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06121804","title":"Immunosuppressants to Postoperative Infection and Death","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT06535568","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","phase":"NA","overall_status":"RECRUITING","enrollment_count":576,"lead_sponsor_name":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","has_results":false},{"nct_id":"NCT05282875","title":"Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis","phase":"","overall_status":"UNKNOWN","enrollment_count":430,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT06881927","title":"Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":212,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT05872815","title":"Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"The Second Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT07024238","title":"Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":41,"lead_sponsor_name":"University Hospital, Martin","has_results":false},{"nct_id":"NCT06951581","title":"Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"University Hospital, Martin","has_results":false},{"nct_id":"NCT06095895","title":"Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04310592","title":"Natural Killer Cell (CYNK-001) Infusions in Adults with AML","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Celularity Incorporated","has_results":false},{"nct_id":"NCT04489420","title":"Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Celularity Incorporated","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}